ANVISA registration

HEMOGLOBINA A1c DIRETA DIALAB

Registration 10300390302. HEMOGLOBINA GLICADA (HbA1C)

Registration details

Registration number10300390302
Application number25351774785201839
Technical nameHEMOGLOBINA GLICADA (HbA1C)
Risk classII
Published on17/12/2018
ValidityIndefinite validity

Registration holder

Legal nameVYTTRA DIAGNOSTICOS S.A.
CNPJ00.904.728/0001-48

Manufacturer

  • DIALAB GMBH ÁUSTRIA

Other registrations held by VYTTRA DIAGNOSTICOS S.A.view all

ANTI- ESTREPTOLISINA O (ASO)

10300390070

ANTICORPOS ANTI-NUCLEARES HEp-2 (ANA HEP - 2)

10300390074

ANTICORPOS ANTI-DNA NATIVO (n-DNA)

10300390076

ANTÍGENO ANTI-ESTREPTOLISINA O (ASO)

10300390078

ANTICORPOS ANTICÉLULAS DAS ILHOTAS (AICA)

10300390079

ANTICORPOS ANTI-PELE (ASA)

10300390080

Source: ANVISA

Source: ANVISA open data, medical device file, updated daily. The public database provides registration validity, rather than registration status: this registration may have been cancelled before its expiry date without this being shown here. Before making purchasing, import or marketing decisions, check the ANVISA search portal.

Next step

Medical device registration with ANVISA

HSC manages the process from risk classification to liaising with the regulator, in Brazil and more than 40 other countries.

Speak to a specialist